ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessment of Physical Performance After Oral Supplementation of Magnesium in a Sample of Old Women in Good Health (Magnesium)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01971424
Recruitment Status : Completed
First Posted : October 29, 2013
Last Update Posted : October 29, 2013
Sponsor:
Information provided by (Responsible Party):
Giuseppe Sergi, University of Padova

Brief Summary:
Magnesium deficiency is associated also in the elderly with low physical performance; nevertheless trials about the effect of supplementation of magnesium on physical performance are not available in old people. The aim of our study is to investigate whether 12-weeks of oral magnesium supplementation improves physical performance in healthy elderly women

Condition or disease Intervention/treatment Phase
Age Related Muscle Loss Dietary Supplement: Mg oxide Other: healthy diet Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Study Start Date : January 2012
Actual Primary Completion Date : March 2013
Actual Study Completion Date : March 2013

Resource links provided by the National Library of Medicine


Arm Intervention/treatment
Experimental: Mg oxide
Participants were supplemented for 12-weeks with 300 mg of daily oral magnesium oxide.
Dietary Supplement: Mg oxide
Other Name: Magnesium oxide

Other: healthy diet
No Intervention: Controls
The control group was educated by a trained dietician to follow a healthy diet.



Primary Outcome Measures :
  1. Changes in short physical performance battery (SPPB) [ Time Frame: Baseline and after 12 weeks ]

Secondary Outcome Measures :
  1. Changes in appendicular skeletal mass (ASMMI) [ Time Frame: Baseline and after 12 weeks ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years and older   (Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • People over 65 years, not residents in nursing home, in good health

Exclusion Criteria:

  • previous supplementation of calcium, potassium or magnesium
  • use of pump proton inhibitors or digitalis
  • important co-mordidities such renal failure

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01971424


Locations
Italy
Geriatrics Division, Department of Medicine
Padova, Italy, 35128
Sponsors and Collaborators
University of Padova

Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Giuseppe Sergi, Medical Doctor, University of Padova
ClinicalTrials.gov Identifier: NCT01971424     History of Changes
Other Study ID Numbers: 2011491
First Posted: October 29, 2013    Key Record Dates
Last Update Posted: October 29, 2013
Last Verified: October 2013

Keywords provided by Giuseppe Sergi, University of Padova:
magnesium
SPPB
strength
physical performance
24 hour magnesuria

Additional relevant MeSH terms:
Magnesium Oxide
Antacids
Molecular Mechanisms of Pharmacological Action
Gastrointestinal Agents